Immunomodulatory role of histamine H4 receptor in breast cancer

OPUS, Oxaliplatin and Cetuximab in First-Line Treatment of Metastatic Colorectal Cancer; PEAK, Panitumumab Efficacy in Combination With mFOLFOX6 Against Bevacizumab Plus mFOLOFOX6

SFKs participate in the development and progression of several human cancers, including breast cancer. To investigate the role of c-Src in the first steps that lead to metastasis,

Bevacizumab plus weekly paclitaxel improves progression-free survival (PFS) in HER2-negative metastatic breast cancer (mBC), but its use has been questioned due to the absence of

Given the much higher efficiencies for solar H 2 -generation from water achieved at tandem PEC/PV devices ( > 10% solar-to-H 2 energy efficiency under simulated sunlight) compared

In this thesis, we have focussed on two different aspects of the pathway: in the first place, we have analysed the in vivo effects of the pharmacological inhibition of PI3K, a

We  have  also  used  a  different  tumour  model  to  analyse  the  mitogenic  signalling  from  apoptotic  cells.  We  have  so  far  tested  the  role  of 

Conclusion Both TNM staging and histological/molecular biomarkers are associated with overall survival in Spanish women with breast cancer; when both are combined in the

Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in